Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03751007
Brief Title: A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recently Diagnosed Type 1 Diabetes Mellitus (T1D)

First Submitted : November 8, 2018
First Submitted that Met QC Criteria : November 20, 2018
First Posted : November 23, 2018

Last Update Submitted that Met QC Criteria : December 5, 2019
Last Update Posted : December 9, 2019